This study is completed in the United States, in India, in Romania, .... It is testing two Doses of Lurasidone for schizophrenia.
SchizophreniaDrugFrom 18 Years to 75 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Two Doses of Lurasidone may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Two Doses of Lurasidone, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in India, in Romania, and in Russia.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateOctober 2008
Recruitment status
Completed
Enrollment listed in the registry
488
Sponsor
Sumitomo Pharma America, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, India, Romania, ...
Age range
From 18 Years to 75 Years
Official registry ID
NCT00790192
Official title
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00790192. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
India · 10 sites
S.V. Medical College
Tirupati, Andhra Pradesh
Site status: Not listed — confirm with the team
Vijayawada Institute of Mental Health and Neurosciences
Vijayawada, Andhra Pradesh
Site status: Not listed — confirm with the team
Seth K M School of P G Medicine & Research
Ahmedabad, Gujarat
Site status: Not listed — confirm with the team
SBKS Medical Institute and Research Centre
Vadodara, Gujarat
Site status: Not listed — confirm with the team
Justice K.S. Hegde Charitable Hospital
Mangalore, Karnataka
Site status: Not listed — confirm with the team
JSS Medical College and Hospital
Mysore, Karnataka
Site status: Not listed — confirm with the team
Shanti Nursing Home
Aurangabad, Maharashtra
Site status: Not listed — confirm with the team
Deenanath Mangeshkar Hospital and Research Centre
Pune, Maharashtra
Site status: Not listed — confirm with the team
Mahatma Gandhi Institute of Medical Sciences
Sewāgrām, Maharashtra
Site status: Not listed — confirm with the team
Madras Medical College & Government General Hospital
Chennai, Tamil Nadu
Site status: Not listed — confirm with the team
Romania · 6 sites
Spitalul Clinic Judetean de Urgenta Arad
Str. Octavian Goga Nr. 17, Arad
Site status: Not listed — confirm with the team
Spitalul de Psihiatrie Titan "Dr. Constantin Gorgos"
Bdul Nicolae Grigorescu Nr. 41, Bucharest
Site status: Not listed — confirm with the team
Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia
Sos. Berceni Nr. 10-12, Bucharest
Site status: Not listed — confirm with the team
Spitalul Judetean Arges
Str. Negru Voda Nr. 53, Pitesti
Site status: Not listed — confirm with the team
Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia
Bucharest
Site status: Not listed — confirm with the team
Spitalul Clinic de Neurologie si Psihiatrie Oradea
Oradea
Site status: Not listed — confirm with the team
Russia · 11 sites
SEI of H.P. Educat. Northern SMU
Arkhangelsk
Site status: Not listed — confirm with the team
St. Petersburg SHI Psychiatrical Hosptial #1 n.a. Kaschenko
Gatchina
Site status: Not listed — confirm with the team
Moscow Scientific Research Institute of Psychiatry
Moscow
Site status: Not listed — confirm with the team
Institution of RAMS Mental Health Research Center of RAMS
Moscow
Site status: Not listed — confirm with the team
City Clinical Psichiatric Hospital #1
Nizhny Novgorod
Site status: Not listed — confirm with the team
City Psychiatric Hospital #2 of St. Nikolay Chudotvorets
Saint Petersburg
Site status: Not listed — confirm with the team
City Psychiatric Hospital #3 of Skvortsov-Stepanov
Saint Petersburg
Site status: Not listed — confirm with the team
City Psychiatric Hospital #4
Saint Petersburg
Site status: Not listed — confirm with the team
SHI City Psychoneurological Dispensary #7
Saint Petersburg
Site status: Not listed — confirm with the team
St. Petersburg GUZ City Psychiatric Hospital #6
Saint Petersburg
Site status: Not listed — confirm with the team
SHI Samara Psychiatric Hospital
Samara
Site status: Not listed — confirm with the team
Ukraine · 9 sites
Kherson Regional Psychiatric Hospital
Kherson,vil., Stepanovka
Site status: Not listed — confirm with the team
RCH n.a.I.I.Mechnikov, Reg.Cent. of Psychosom. Pathology
Dnipropetrovsk
Site status: Not listed — confirm with the team
Chair of Psychiatry and Medical Psychology
Donetsk
Site status: Not listed — confirm with the team
Centre of Novel Treatment and Rehabilitation of Psychotic disorders
Kyiv
Site status: Not listed — confirm with the team
Kyiv City Psychoneurological Hospital
Kyviv
Site status: Not listed — confirm with the team
Lviv Reg.St.Cl.Psych.Hosp
Lviv
Site status: Not listed — confirm with the team
Reg. Psychiatric Hospital
Odesa
Site status: Not listed — confirm with the team
Poltava Regional Clinical Psychiatric Hospital,
Poltava
Site status: Not listed — confirm with the team
Crimean republican Clinical Psychiatric Hospital
Simferopol
Site status: Not listed — confirm with the team
United States · 29 sites
K&S Professional Research Services, LLC
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Woodland International Research Group
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Clinical Pharmacological Studies, Inc.
Cerritos, California
Site status: Not listed — confirm with the team
Comprehensive Neuroscience, Inc
Cerritos, California
Site status: Not listed — confirm with the team
Clinical Innovations, Inc.
Costa Mesa, California
Site status: Not listed — confirm with the team
Synergy Escondido
Escondido, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Network
Garden Grove, California
Site status: Not listed — confirm with the team
Apostle Clinical Trials, Inc.
Long Beach, California
Site status: Not listed — confirm with the team
California Clinical Trials
Paramount, California
Site status: Not listed — confirm with the team
Pasadena Research Institute
Pasadena, California
Site status: Not listed — confirm with the team
CNRI-Los Angeles. LLC
Pico Rivera, California
Site status: Not listed — confirm with the team
Clinical Innovations, Inc.
Riverside, California
Site status: Not listed — confirm with the team
CNRI-San Diego
San Diego, California
Site status: Not listed — confirm with the team
UCSD Medical Center
Sandeigo, California
Site status: Not listed — confirm with the team
Segal Institute for Clinical Research
Highlands Ranch, Colorado
Site status: Not listed — confirm with the team
Comprehensive Neuroscience, Inc.
Washington D.C., District of Columbia
Site status: Not listed — confirm with the team
Florida Clinical Research Center
Bradenton, Florida
Site status: Not listed — confirm with the team
Florida Clinical Research Center, LLC
Fruitland Park, Florida
Site status: Not listed — confirm with the team
Lake Charles Clinical Trials
Lake Charles, Louisiana
Site status: Not listed — confirm with the team
Booker, J. Gary, MD. APMC
Shreveport, Louisiana
Site status: Not listed — confirm with the team
Precise Clinical Research
Flowood, Mississippi
Site status: Not listed — confirm with the team
St. Charles Psychiatric Associates
Saint Charles, Missouri
Site status: Not listed — confirm with the team
St. Louis Research, Inc.
St Louis, Missouri
Site status: Not listed — confirm with the team
CRI Worldwide
Willingboro, New Jersey
Site status: Not listed — confirm with the team
Comprehensive Neuroscience, Inc
Holliswood, New York
Site status: Not listed — confirm with the team
Segal Institute for Clinical Research
Winston-Salem, North Carolina
Site status: Not listed — confirm with the team
Community Clinical Research
Austin, Texas
Site status: Not listed — confirm with the team
Future Search Trials of Neurology
Austin, Texas
Site status: Not listed — confirm with the team
Pillar Clinical Research
Dallas, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Lurasidone, Quetiapine XR, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 75 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
